Africa needs to help model the future of tuberculosis vaccines
The Lancet Microbe · 2026-11 · 101574
DOI: 10.1016/j.lanmic.2026.101574 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Microbe, 2026-11. Verfasst von Akaninyene Otu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Centre for International Health and Development, University of Leeds, Leeds, LS2 9JT, UK; Mid Yorkshire Teaching Hospital NHS Trust, Wakefie…. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The tuberculosis (TB) vaccine pipeline is entering a new era. As da Costa and colleagues noted in their Series, 18 vaccine candidates are in clinical development, including six in phase 3.1,2 M72/AS01E has shown approximately 50% activity against pulmonary TB disease in infected adults, with phase 3 evaluation under way.1,2 These advances offer an unprecedented opportunity to accelerate progress towards End TB targets. However, they also raise a neglected question: who will generate the modelling evidence that determines where, when, and how these vaccines should be used?
Autor:innen und Institutionen
- Nuffield Centre for International Health and Development, University of Leeds, Leeds, LS2 9JT, UK; Mid Yorkshire Teaching Hospital NHS Trust, Wakefield, UK. Electronic address: a.a.otu@leeds.ac.uk.
- Department of Public Health, Faculty of Allied Medical Sciences, College of Medical Sciences, University of Calabar, Calabar, Nigeria; Corona Management Systems, Plot 2014, CAD Zone B09, Celina Ayom Crescent, Kado, Abuj…
- Department of Public Health, Sefako Makgatho Health Sciences University, Pretoria, South Africa; SAMRC/SMU Public Health Interventions, Innovations and Implementation Research Unit, Sefako Makgatho Health Sciences Unive…
- The National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.
- Corona Management Systems, Plot 2014, CAD Zone B09, Celina Ayom Crescent, Kado, Abuja, Nigeria.
Zitieren
APA
Otu, A., Onwusaka, O., Oladimeji, O., Adebayo, E., & Kaduru, C. (2026). Africa needs to help model the future of tuberculosis vaccines. The Lancet Microbe, 101574. https://doi.org/10.1016/j.lanmic.2026.101574
Vancouver
Otu A, Onwusaka O, Oladimeji O, Adebayo E, Kaduru C. Africa needs to help model the future of tuberculosis vaccines. The Lancet Microbe. 2026:101574. doi:10.1016/j.lanmic.2026.101574
BibTeX
@article{Otu2026,
author = {Otu, Akaninyene and Onwusaka, Obiageli and Oladimeji, Olarenwaju and Adebayo, Ekosanmi and Kaduru, Chijioke},
title = {Africa needs to help model the future of tuberculosis vaccines},
journal = {The Lancet Microbe},
year = {2026},
pages = {101574},
doi = {10.1016/j.lanmic.2026.101574}
}
EUVIMED